Hormones

Anastrozole

Evidence: strong_human

Mechanism of Action

Anastrozole is a potent, selective, non-steroidal third-generation aromatase inhibitor that competitively binds the heme group of cytochrome P450 aromatase (CYP19A1), blocking the conversion of testosterone to estradiol and androstenedione to estrone. In men on TRT, this reduces circulating estradiol by 50-80%, shifting the testosterone-to-estradiol ratio favorably. Estrogen suppression releases hypothalamic negative feedback, increasing GnRH, LH, and FSH secretion in non-TRT contexts. Complete estrogen ablation is detrimental to bone density, lipid metabolism, and cognitive function.

Dosing Protocol

Standard: Research indicates 0.25-0.5 mg twice weekly as a TRT adjunct for estrogen management. Stand-alone hypogonadism: 1 mg twice weekly.

Maintenance: Research indicates 0.25-0.5 mg once or twice weekly, titrated to maintain estradiol at 20-40 pg/mL (sensitive assay).

Administration: oral

Timing: Take on testosterone injection days or the day after when aromatization peaks. Consistent schedule for stable estradiol control.

Duration: Ongoing as needed alongside TRT. Reassess every 3-6 months with estradiol labs. Goal is minimal effective dose.

Notes

CRITICAL: Over-suppression of estradiol is a common and serious error in TRT management. Estradiol is essential for male bone density, cardiovascular health, libido, cognition, and joint function. Target estradiol: 20-40 pg/mL on sensitive assay — not 'as low as possible.' Many men on TRT do not need an AI at all; only use if symptomatic high E2 is confirmed by labs. Required bloodwork: Estradiol (sensitive/LC-MS/MS assay — standard immunoassay is inaccurate in males), total testosterone, lipid panel, DEXA scan annually if on chronic AI. Joint pain or low libido on AI warrants immediate estradiol check. Medical supervision required.

Stacking

  • Testosterone Cypionate/Enanthate (primary adjunct use)
  • hCG (hCG increases intratesticular aromatization — AI may be needed)

Interactions

  • Testosterone (all esters) [LOW] — Primary intended combination — anastrozole manages estrogen from testosterone aromatization.
  • Tamoxifen [MEDIUM] — Tamoxifen inhibits CYP3A4, reducing anastrozole plasma levels by ~27%. Avoid combination.
  • Estrogen-containing preparations [HIGH] — Directly antagonistic — estrogen supplementation counteracts anastrozole's mechanism.

Contraindications

  • Premenopausal women
  • Known hypersensitivity to anastrozole
  • Pre-existing severe osteoporosis (estrogen suppression worsens bone loss)
  • Children (may affect bone growth plate closure)

Side Effects

  • Joint pain and stiffness (from excessive estrogen suppression)
  • Bone density loss with chronic use
  • Lipid profile worsening (HDL suppression)
  • Fatigue and brain fog (from over-suppression of estradiol)
  • Mood disturbances and depression
  • Hot flashes
  • Decreased libido (if estradiol drops below ~15 pg/mL)

Key Papers

  • 10.1210/jc.2003-031644
  • 10.1016/j.fertnstert.2003.10.048
  • 10.1093/humrep/15.10.2251

Source Quality

FDA-approved pharmaceutical product (Arimidex). Generic anastrozole widely available. 1 mg tablets can be split or compounding pharmacies can prepare 0.125 mg or 0.25 mg capsules for micro-dosing.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Anastrozole Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds